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Abstract
Unaccustomed eccentric exercise damages skeletal muscle tissue, activating mechanisms of recovery and remodeling that
may be influenced by the female sex hormone 17b-estradiol (E2). Using high density oligonucleotide based microarrays, we
screened for differences in mRNA expression caused by E2 and eccentric exercise. After random assignment to 8 days of
either placebo (CON) or E2 (EXP), eighteen men performed 150 single-leg eccentric contractions. Muscle biopsies were
collected at baseline (BL), following supplementation (PS), +3 hours (3H) and +48 hours (48H) after exercise. Serum E2
concentrations increased significantly with supplementation (P,0.001) but did not affect microarray results. Exercise led to
early transcriptional changes in striated muscle activator of Rho signaling (STARS), Rho family GTPase 3 (RND3), mitogen
activated protein kinase (MAPK) regulation and the downstream transcription factor FOS. Targeted RT-PCR analysis
identified concurrent induction of negative regulators of calcineurin signaling RCAN (P,0.001) and HMOX1 (P=0.009).
Protein contents were elevated for RND3 at 3H (P=0.02) and FOS at 48H (P,0.05). These findings indicate that early RhoA
and NFAT signaling and regulation are altered following exercise for muscle remodeling and repair, but are not affected by
E2.
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Introduction
Myofibres have the capacity to be remodeled to best meet their
functional and metabolic demands. Changes in physical activity
can initiate a remodeling process toward increased (hypertrophy)
or decreased (atrophy) muscle mass [1,2,3]. Through protein
signaling pathways, integration of chemical, mechanical and
bioenergetic signals change the genetic expression patterns for
cell size, function and metabolic processes [4]. Physical activities
that incorporate unaccustomed eccentric contractions are typically
associated with high levels of muscle damage, inflammation and
delayed onset muscle soreness (DOMS) [5,6,7]. Eccentric
contractions, identified by a lengthening while under tension,
create an insult to myofibres which may be characterized by:
damage to the sarcoplasmic reticulum [5], t-tubules [8] and
structural proteins [6,9,10], the presence of muscle protein in
blood [11,12], Z-line streaming [13,14], soreness and fatigue [7,8].
Murine and rodent research has often indicated an attenuation
of exercise induced membrane damage [15,16,17,18,19], struc-
tural proteins [20], and inflammation [21,22,23,24] along with
enhanced satellite cell activation [21,25,26] with exposure to the
sex hormone 17b-estradiol (E2). This reduced muscle damage and
improved recovery may result from potential antioxidant,
membrane stabilizing, or gene regulation properties of E2
[27,28,29,30,31]. As the most abundant estrogen, E2 exerts
estrogenic properties that affect the differentiation, growth and
function of reproductive, skeletal, neural and muscular tissues
[31,32]. However, human studies do not consistently support the
effectiveness of E2 to attenuate exercise-induced muscle damage,
mostly reporting similar values for CK efflux, inflammation and
loss of muscle function when comparing men and women [6,33].
Recent microarray analyses have uncovered novel transcrip-
tional programs that coordinate the regeneration and repair of
damaged muscle following eccentric exercise [10,34,35]. These
studies have indentified clusters of genes representing important
mechanisms for recovery and adaptation that include the
regulation of inflammation [10,35], growth [10,35], stress response
proteins [10,34] and membrane biosynthesis [34]. Similar analyses
have also described sex differences in the expression levels of genes
involved in metabolism and growth inhibition that may result from
variations in body composition and hormone content [36,37,38].
Specifically, women express a higher abundance of mRNA for
several genes involved in fat metabolism that include trifunctional
protein b and lipoprotein lipase [36], and greater expression of the
negative regulators of the anabolism growth factor receptor-bound
10 and activin A receptor IIB [37].
The effect of E2 administration on the transcriptome expression
profile of skeletal muscle following a single bout of intense
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microarray analysis to identify how global mRNA abundance is
altered by E2 supplementation in men after 150 eccentric
contractions. We hypothesized that the anti-oxidant and mem-
brane stabilizing properties of E2 would attenuate the amount of
muscle damage experienced, thereby modifying the expression of
mRNA species involved in membrane homeostasis, growth and
stress management. Furthermore, we hypothesized that the use of
gene array analysis would allow us to detect novel genes relevant
to the hypertrophic growth signaling stimulated by intense
exercise.
Materials and Methods
Ethics statement
All participants were given an information sheet describing all of
the testing procedures before providing written consent to
participate. The study conformed to the standards outlined in
the Declaration of Helsinki and was given approval by the Research
Ethics Board of McMaster University (05–438).
Subjects and anthropometrics
Eighteen young healthy men volunteered as participants in this
study. All subjects were pre-screened to ensure that they were
healthy, fit and had not regularly participated in resistance
exercise in the preceding 6 months. Body composition was
measured using dual energy x-ray absorptiometry (DEXA) scans
(GE Lunar Prodigy, Fairfield, CT). Thigh muscle cross-sectional
area was calculated using anthropomorphic measurements of mid-
thigh circumference and skinfold thickness [39] to control for
potential differences in total work completed. The subject
demographics were (mean 6 SD): age, 2162 y; height,
18165 cm; weight, 76.9612.8 kg.
Supplementation protocol
Subjects were assigned in a randomized, double-blind manner
to either a control (CON, N=9) or experimental (EXP, N=9)
group. CON subjects consumed 400 mg glucose polymer (Poly-
cose; Abbott Laboratories, Ross Division, St. Laurent, Quebec,
Canada) for 10 days. EXP subjects consumed ,300 mg glucose
with 1 mg E2 (Estrace; Shire BioChem, Inc., St. Laurent, Quebec,
Canada) for 2 days followed by 2 mg E2 for 8 days. We have
previously used this protocol to increase serum E2 concentrations
to levels seen during the luteal phase of the menstrual cycle [40].
Glucose and E2 tablets were concealed in gelatin capsules. On the
morning of the ninth day, subjects reported to the laboratory and
performed the exercise protocol. Supplementation continued until
the day of the final biopsy and blood collection to maintain serum
E2 concentrations throughout the collection protocol. Subjects in
both groups were instructed to take one pill at the same time each
day and return any unused pills. All subjects reported 100%
compliance.
Exercise protocol and tissue collection
Muscle damage was induced with a previously developed
eccentric exercise protocol [41]. Approximately 2 weeks before the
exercise protocol, subjects were given a familiarization session with
a Biodex isokinetic dynamometer (System 3, Biodex Medical
Systems Inc., Ronkonkoma, NY). On the testing day, following a
short warm-up (10 min of light cycling), subjects were seated in the
dynamometer with their right leg strapped to a lever arm. The
lever arm was programmed to extend their leg to 150u of flexion
(where 180u is full extension) at a moderate speed (30u/s), then flex
their leg to 90u of flexion at a faster speed (120u/s). Subjects did
not have to contract maximally during the extension phase.
During the flexion phase, subjects were instructed to attempt to
maximally resist flexion of the knee (i.e. voluntary ‘maximal’
contraction) against the descending lever arm throughout the
entire range of motion. The complete test consisted of 15 sets of 10
repetitions, each set separated by 1 minute of rest.
Prior to each tissue collection, subjects abstained from any other
form of physical exertion (within 72 h), avoided alcohol (within
48 h), ate their habitual diet (within 48 h), and abstained from
caffeine (within 12 h). Each subject consumed a 350 Kcal defined
formula diet (57% carbohydrates, 15% protein and 28% fat) two
hours before each muscle biopsy and did not eat again until after
the final biopsy of each session was taken. These nutritional and
activity controls were taken to ensure that the muscle damage
would be the only variable to differentially affect the outcomes
between biopsies [42].
Muscle biopsies were taken from the vastus lateralis of the
control (left) leg during the familiarization session (baseline, BL)
and after 8 days of supplementation (post supplementation, PS)
and the exercised (right) leg 3 hours (3H) and 48 hours (48H) after
exercise, in anatomically distinct sites approximately 6 cm apart
[43]. The post exercise collection times were chosen because they
represent two distinct phases of recovery from muscle damage [6].
The muscle biopsies were quickly dissected of fat and connective
tissue, sectioned into RNase-free cryovials (,30 mg/piece), flash
frozen with liquid nitrogen and stored at 286uC until analysis.
Blood samples were drawn from the antecubital vein into
heparinized tubes at the same collection times, placed on ice,
centrifuged at 1750 g at 4uC for 10 min and stored at 220uC
future analyses.
Blood hormone and enzyme concentrations
Serum E2 (Fertigenix-E2-EASIA, Biosource Europe S.A,
Nivelles, Belgium) and testosterone (Fertigenix-TESTO-EASIA,
Biosource Europe S.A, Nivelles, Belgium) concentrations were
measured by enzyme amplified-sensitivity immunosorbent assays
(EASIA) according to manufacturer’s specifications using BL and
PS blood collections. Serum lactate dehydrogenase (LDH)
activities were measured in BL, 3H and 48H blood collections
with a colourimetric LDH quantification assay (K726-500,
Biovision Research Products, Mountain View, CA) according to
manufacturer’s specifications. All hormone and enzyme measure-
ments were done in duplicate.
RNA extraction
The total RNA was extracted from the frozen skeletal muscle
biopsy as described previously in detail by our group [43]. Briefly,
,30 mg of skeletal muscle was homogenized on ice in 2 mL of
Trizol Reagent (Life Technologies, Cat. No. 15596, Gaithersburg,
MD). The homogenate was incubated for 10 min at room
temperature, followed by phase separation using 200 mLo f
chloroform and precipitation of the total RNA from the aqueous
phase using 500 mL of isopropyl alcohol. The RNA pellet was then
washed three times in 75% ethanol and re-suspended in 15 mL
DEPC-treated water, aliquoted, and stored at 286uC. The
concentration and purity of the RNA was determined using a
UV spectrophotometer (Shimadzu UV-1201; Mandel Scientific,
Guelph, Ontario) at the absorbance of 260/280 nm. Measure-
ments were done in duplicate and had an average coefficient of
variation (CV) of ,10%. The average purity (OD260/OD280)o f
the samples was 1.7 before DNase treatment. RNA integrity was
assessed in a randomly chosen subset of samples using agarose gel
electrophoresis, and the OD ratio of 28S to 18S rRNA was
consistently greater than 1 for each sample.
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Prior to microarray chipping and real time quantitative RT-
PCR analysis, the isolated RNA samples were treated with DNA-
free
TM recombinant DNase I (Ambion Inc, Austin, TX) according
to the manufacturer’s instructions to remove any potential
genomic DNA contamination.
Microarray analysis
The resulting total RNA samples were further assessed for
integrity prior to chipping using a Nanodrop Spectrophotom-
eter and the Agilent Bioanalyzer Nano Chip System. Samples
which passed this initial quality control assurance step were then
amplified one round, using an Illumina TotalPrep Kit (Ambion)
to generate cDNA then cRNA according to the manufacturer’s
instructions. This was again assessed for quality by using the
Nanodrop and Bioanalyzer as described above. Labeled cRNA
samples that passed this second round of quality control were
then hybridized to Human Ref-8 BeadChips (Illumina) accord-
ing to the manufacturer’s instructions (approximately 23,000
genes), using equipment specified by the manufacturer (Illu-
mina). Briefly, 850 ng biotin-labeled cRNA in 11.3 mln u c l e a s e -
free water was adjusted to 34 ml through the addition of 22.7 ml
of 5:3 HybE1 buffer/formamide. The sample was heated at
65uC for 5 min, allowed to cool to room temperature, and then
immediately added to a single array of an 8-array Human Ref-8
BeadChip. Once all 8 samples were added to each BeadChip, it
w a ss e a l e di naH y bC a r t r i d g ea n di n c u b a t e df o r1 6ha t5 5 uC
with rotation in an Illumina hybridization oven (rotation setting
5). Following overnight hybridization, BeadChips were moved
to a slide rack and serially washed using gentle rotation in glass
staining dishes filled with a) 250 ml Illumina Wash Buffer65-
min, b) 250 ml 100% ethanol610 min, c) 250 ml Illumina
Wash Buffer62 min. BeadChips were then blocked for 10 min
in 4 ml Block E1 buffer (Illumina), followed by staining for
1 0m i ni n1mg/ml Streptavidin-Cy3 conjugate (GE Healthcare)
in Block E1 buffer. Stained BeadChips were finally washed
using gentle rotation in a glass staining dish filled with 250 ml
Illumina Wash Buffer65 min. BeadChips were dried by
centrifugation at 280 g for 4 min and stored in a light-tight
box until reading.
Array reading
Processed arrays were read using a BeadStation array reader
(Illumina) according to the manufacturer’s instructions.
Gene ontology analysis
In the lists of genes that were significantly differentially expressed
with exercise in our study, we carried out gene ontology (GO)
analysis to determine the relative enrichment of genes with
common or related functionalities to gain insight into biological
processes mediated by E2 or exercise. This was carried out using
the web interface driven GoMiner tool using an FDR of 5% [44].
Genes were also referenced to their biological functions and
canonical pathways with Ingenuity Pathway Analysis (IPA)
software. This software identifies functions and pathways most
significant to the data set in two ways: the number of differentially
expressed genes included in a pathway or function and calculation
of a p-value using a Fisher’s Exact Test to determine the probability
of the association of the data set.
Real-time RT-PCR analysis
Changes in gene expression relative to baseline values were
measured using real-time reverse transcription-polymerase chain
reaction (RT-PCR). Regulator of calcineurin 1 (RCAN1) and
capping protein (actin filament) muscle Z-line, alpha 1 (CAPZA1)
were selected for analysis because of their roles in growth and
sarcomerogenesis [34]. Hemeoxygenase 1 (HMOX1) was chosen
for analysis because of its role in stress management [45]. The
Table 1. Primer and probe sequences for calcineurin regulation, actin dynamics and housekeeping genes.
Gene Left Primer Right Primer Probe
RCAN1 gacaaggacatcacctttcagt tcatttcctttcccagaaactc caaacgagtcagaataacttcagcaaccc
HMOX1 tctccgatgggtccttacac cctgcattcacatggcataa ctaagccaactgtcgccaccagaaa
CAPZA1 ccttccaagcacttctggtact gagggagaaggatgaatgtgt atccaccaacacctaaagaggctatgc
b2M ggctatccagcgtactccaa gatgaaacccagacacatagca tcaggtttactcaacgtcatccagcagag
doi:10.1371/journal.pone.0010695.t001
Table 2. Subject and eccentric exercise trial characteristics.
CON EXP
No. of subjects 9 9
Age, yr 21.160.8 20.960.9
Height, cm 181.662.0 180.961.4
Weight, kg 73.463.8 80.464.6
Body fat, % 14.761.7 20.162.4
Quadriceps CSA, cm
2 74.463.3 78.564.1
Work, kJ 24.962.9 25.161.3
Values are means 6 SEM.
doi:10.1371/journal.pone.0010695.t002
Table 3. Serum hormone concentrations after 8d of
supplementation with either placebo (CON) or E2 (EXP).
Estradiol (pg/ml) BL PS
CON 36.462.5 38.462.8
EXP 38.864.0 95.4611.7
***
Testosterone (nmol/L) BL PS
CON 14.662.0
EXP 10.862.1
**
Values are mean 6 SEM.
**P,0.01.
***P,0.001.
N=9/group.
doi:10.1371/journal.pone.0010695.t003
mRNA Regulation after Exercise
PLoS ONE | www.plosone.org 3 May 2010 | Volume 5 | Issue 5 | e10695selected housekeeping gene was b2-microglobulin. Its constant
expression following eccentric exercise has been shown in previous
work [43], and was confirmed for the current study. The
efficiencies of all primers were tested and determined to be
greater than 98%. The primer and probe sequences for these
genes can be found in Table 1.
RT-PCR was completed using a TaqManH real-time method.
The primers and a probe to each target gene were designed based
on the cDNA sequence in GenBank (http://www.ncbi.nlm.nih.
gov/sites/entrez/?db=gene) with primer 3 designer (http://frodo.
wi.mit.edu/primer3-0.4.0/input.htm). All target gene probes were
labeled with FAM at their 59 ends and BHQ-1 at their 39 ends.
Duplex RT-PCR was performed on an iCycler real-time PCR
system (Bio-Rad Laboratories, Hercules, CA) in the One-step
TaqManH RT-PCR Master Mix Reagents (Roche, Branchburg,
New Jersey) according to the manufacture’s instruction with target
gene primers, target probe, housekeeping gene primers and
housekeeping gene probe in the same reaction [46]. Determina-
tion of significant gene expression change was done as previously
described [46]. The genes of interest were normalized to the
housekeeping gene, b2-microglobulin by following the standard
method. Briefly, CT values of the housekeeping gene were
subtracted from the CT values of the gene of interest giving a
dCT. This is equivalent to the log2 difference between endogenous
control and target gene [47]. Values were then normalized to
baseline, ddCT. All samples were run in triplicate, fluorescence
emission was detected using FAM and Tamra filters, and CT was
automatically calculated.
Western blotting
Muscle biopsy samples were homogenized and prepared for
polyacrylamide gel electrophoresis using methods previously
described [48]. Briefly, frozen skeletal muscle tissue samples (25–
35 mg) were hand homogenized in 25 ml of phosphate buffer
(50 mM Kpi, 5 mM EDTA, 0.5 mM DTT, 1.15%KCl (w/v)) per
milligram of tissue. A protease inhibitor cocktail (Sigma, St. Louis,
Missouri) was added to the phosphate buffer immediately prior to
use at a ratio of 1:1,000. Samples were centrifuged at 600 g for
10 min at 4uC and the supernatant aliquoted for analyses. Protein
concentrations of each sample were determined using the method
described by Lowry et al [49].
Samples were loaded on 10% SDS-polyacrylamide gels and
transferred to a PVDF membrane. Membranes were blocked with
5% BSA (wt/vol) in Tris-buffered saline with 0.1% Tween (vol/
vol) (TBST) and incubated in primary antibody: RND3 (Abcam,
Cambridge, MA; ab50316, 1:1000); FOS (Abcam; ab16902,
1:1000); total p38MAPK (Cell Signaling Technology, Danvers,
MA; no. 9212, 1:1000); p38MAPK (Thr180/Tyr182) (Cell
Signaling Technology; no. 9215, 1:1000); total GSK-3b
(Cell Signaling Technology; no. 9315, 1:1000); GSK-3b (Ser 9)
(Cell Signaling Technology; no. 9323, 1:1000), b-actin (BD
Biosciences, Mississauga, ON; no. 612657, 1:10000). After
washing in TBST, membranes were incubated in either HRP-
linked anti-rabbit or anti-mouse IgG secondary antibody (Amer-
sham Biosciences, Piscataway, NJ; no. NA934V, 1:6000), washed
with TBST and developed using ECL (Amersham Biosciences;
model no. RPN2106). Membranes were exposed to x-ray film
(Biomax XAR; Kodak, Rochester, New York) which were then
scanned with a Dell 920 scanner at 300 DPI and saved in TIF file
format. Using Image J v1.40 g software (National Institutes of
Health, Bethesda, Maryland), background noise was removed and
bands in the region of interest were selected for analysis. Individual
profile plots were generated and area under the curve measured in
arbitrary units (AU).
Statistical and bioinformatics analysis
Student’s unpaired t-tests were used to determine differences in
subject characteristics and total work. A 2-way repeated measures
ANOVA (supplementation protocol 6 time) was used to assess
differences in LDH, E2 concentration, testosterone concentration,
protein levels and the linear 2
2ddCT data set for gene expression
measured with RT-PCR using computerized software (Statistica,
Statsoft). When statistical significance was achieved, Tukey’s
honestly significance difference post-hoc test was used to
determine the significance among the means. STATISTICA for
Windows 5.0 (Statsoft, Tulsa OK) was used to perform t-tests and
ANOVAs. The threshold for significance was set at P#0.05. Data
are presented as mean 6 SEM unless otherwise indicated.
Gene array data analyses were done comparing baseline, post
supplementation, 3 and 48 hours post exercise using simple paired
t-test on log2 expression ratios. Genes were ranked by p-value and
the inference reported following adjustment for multiple testing
using the FDR and the Benjamini and Hochberg method. Among
those genes with an adjusted q-value (based on FDR) of ,0.05, we
used hierarchical clustering (based on the HOPACH algorithm) to
find groups of genes with similar profiles across the subjects.
Results
Subject and work characteristics
CON and EXP groups were not different in age, weight, height,
body fat percentage, average thigh cross-sectional area or total
work completed (Table 2). All subjects completed the required 150
eccentric contractions.
E2 and testosterone concentration were affected by
supplementation with E2
Following 8 days of supplementation serum E2 concentration
increased by 146% (P,0.001) and testosterone concentration was
reduced by 26% (P=0.01) in the EXP group (Table 3). Both
hormone concentrations remained unchanged in the CON group.
Eccentric exercise induced muscle damage
The appearance of the muscle protein LDH in serum is an
indirect indicator of muscle membrane damage. LDH activity was
elevated 13.8% (P,0.05) 48 hours after exercise (Table 4). The
EXP values did not differ from the CON values at any time.
Microarray data identifies altered mRNA expression
during recovery from eccentric exercise that is not
affected by E2
Eccentric exercise significantly increased the early mRNA
expression of 310 genes at 3H. DNA microarray analyses did not
identify differential mRNA expression of any gene as a result of E2
at any time (we could not reject the global null that E2 was
Table 4. Serum lactate dehydrogenase activity following 150
eccentric contractions in CON and EXP groups.
Baseline 3 hours 48 hours*
CON (U/L) 152.368.6 166.166.8 166.3610.9
EXP (U/L) 140.769.7 158.169.2 165.4616.3
Values are mean 6 SEM.
*P,0.05 main effect for group compared to baseline.
CON (N=7), EXP (N=8).
doi:10.1371/journal.pone.0010695.t004
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chip). For this reason, microarray data at each timepoint was
collapsed between groups, increasing the sample size to 18 subjects.
Mean fold change for genes with ratios greater than 1 at 3H was
2.360.1. In addition, 301 genes had ratios less than 1 at 3H with a
mean fold change of 0.860.01. By 48H, all genes had expression
values that were not different from baseline. The complete data set
is freely available at GEO (accession no. GSE19062).
Of the genes differentially expressed at 3H, we identified 25 that
participate in two signaling cascades for muscle growth and
Table 5. Fold change of gene expression after 3 hours of recovery from eccentric exercise using DNA microarray analysis (n=18).
Categories and Gene Names Accession Number Fold change at 3H Potential relevant function
Calcineurin regulation
regulator of calcineurin 1 (RCAN1), transcript variant 3 NM_203418.1 5.6 Calcinuerin regulation
regulator of calcineurin 1 (RCAN1), transcript variant 2 NM_203417.1 3.9 Calcinuerin regulation
NFAT
nuclear factor of activated T-cells, (NFATC1), transcript variant 1 NM_172390.1 1.3 calcineurin transcription/regulation
glycogen synthase kinase 3 beta (GSK3B) NM_002093.2 1.3 calcineurin transcription/regulation
MAPK regulation
Activation
mitogen-activated protein kinase-activated protein kinase 2
(MAPKAPK2), transcript variant 2
NM_032960.2 1.2 MAPKKK cascade
adrenergic, beta-2-, receptor, surface (ADRB2) NM_000024.3 2.5 activation of MAPK activity
mitogen-activated protein kinase 6 (MAPK6) NM_002748.2 1.3 MAP kinase activity
mitogen-activated protein kinase kinase kinase 6 (MAP3K6) NM_004672.3 1.4 protein serine/threonine kinase activity
mitogen-activated protein kinase kinase kinase 8 (MAP3K8) NM_005204.2 11.1 protein serine/threonine kinase activity
Inactivation
protein phosphatase 2 (formerly 2A), catalytic subunit, alpha
isoform (PPP2CA)
NM_002715.2 1.5 inactivation of MAPK activity
dual specificity phosphatase 16 (DUSP16) NM_030640.1 1.8 inactivation of MAPK activity
dual specificity phosphatase 8 (DUSP8) NM_004420.1 1.4 inactivation of MAPK activity
RHOA
striated muscle activator of Rho-dependant signaling (STARS) NM_139166.2 10.1 positive regulation of Rho protein signal
transduction
Rho family GTPase 3 (RND3) NM_005168.3 5.4 small GTPase mediated signal transduction
Rho guanine nucleotide exchange factor (GEF) 7 (ARHGEF7),
transcript variant 2
NM_145735.1 1.3 RHOA positive regulation
Rho guanine nucleotide exchange factor (GEF) 12 (ARHGEF12) NM_015313.1 1.2 RHOA positive regulation
Rho GTPase activating protein 24 (ARHGAP24) NM_031305.1 0.8 RHOA negative regulation
Actin cytoskeleton and transcription factor activity
actinin, alpha 1 (ACTN1) NM_001102.2 1.4 actin cytoskeleton
diaphanous homolog 1 (Drosophila) (DIAPH1) NM_005219.2 1.9 actin cytoskeleton organization and
biogenesis
coronin, actin binding protein, 1C (CORO1C) NM_014325.2 1.5 actin binding/cytoskeleton
filamin B, beta (actin binding protein 278) (FLNB) NM_001457.1 1.5 actin binding/cytoskeleton
actin, alpha 2, smooth muscle, aorta (ACTA2) NM_001613.1 1.7 actin filament
jun D proto-oncogene (JUND) NM_005354.2 1.9 activated transcription factor component
v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) NM_005252.2 14.8 activated transcription factor component
FBJ murine osteosarcoma viral oncogene homolog B (FOSB) NM_006732.1 3.7 activated transcription factor component
v-maf musculoaponeurotic fibrosarcoma oncogene homolog
F (avian) (MAFF), transcript variant 1
NM_012323.2 2.6 regulation of transcription
Other regulators of muscle growth and remodeling
activating transcription factor 3 (ATF3), transcript variant 3 NM_001030287.1 28.4 transcription factor activity
Xin actin-binding repeat containing 1 (XIRP1) NM_194293.2 13.6 actin cytoskeleton organization
v-myc myelocytomatosis viral oncogene homolog (avian) (MYC) NM_002467.3 11.0 transcription factor activity
heparin-binding EGF-like growth factor (HBEGF) NM_001945.1 7.0 growth factor activity
DnaJ (Hsp40) homolog, subfamily B, member 4 (DNAJB4) NM_007034.3 6.1 heat shock protein binding
doi:10.1371/journal.pone.0010695.t005
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nuclear factor of activated T-cells (NFAT) (Table 5). Other
regulators of muscle growth and remodeling not directly involved
in RHOA or NFAT signaling that were also highly induced
included: ATF3, MYC, XIRP1, HBEGF and DNAJB4 (Table 5).
IPA identified several biological functions related to muscle
growth and remodeling identified by the number of differentially
expressed genes included in the function and the calculation of a P-
value using a Fisher’s Exact Test witha threshold forsignificanceset
at P#0.05. They included: cancer (P,0.05, 233 molecules), gene
expression (P,0.05, 146 molecules), cell assembly and organization
(P,0.05, 69 molecules), cell morphology (P,0.05, 59 molecules)
and skeletal and muscular system development and function
(P,0.05, 50 molecules). In the same manner, IPA also identified
three canonical pathways related to gene expression and growth/
proliferation: ILK signaling (P=0.005, 16/186 molecules), RAN
signaling (P=0.005, 4/23 molecules) and PI3K/AKT signaling
(P=0.006, 12/136 molecules).
RT-PCR analysis provides additional genes involved in
actin dynamics and regulation of RhoA and NFAT
signalling
Targeted real time RT-PCR was conducted on several genes
selected a priori for their involvement in recovery from skeletal
muscle damage. Previous work using microarray analysis and RT-
PCR identified the expression of novel genes following a similar
eccentric protocol that are likely involved in the recovery and
adaptation to damaging exercise [34]. Confirming the identifica-
tion of two of its transcript variants in the microarray, RCAN1
mRNA content was highly elevated at 3H (16.6-fold, P,0.001)
(Fig. 1A). Also induced was HMOX1 at both 3H (3.9-fold,
P=0.009) and 48H (3.5-fold, P=0.002) (Fig. 1B).
Expression of CAPZA1, a regulator of the growth of actin
filaments, was increased at 48H (1.8-fold, P=0.04) (Fig. 2).
Signaling proteins and protein content are affected by
eccentric exercise
Phosphorylated p38MAPK and GSK-3b negatively regulate
NFAT by promoting its export from the nucleus. Phosphorylation
(Thr
180/Tyr
182) of p38MAPK was significantly lower at 3H (0.77-
fold, P=0.07) and 48H (0.73-fold, P=0.005) as a result of exercise
with no effect of E2 (Fig. 3A). Phosphorylation (Ser
9) of GSK-3b
was not affected by either exercise or E2 (Fig. 3B).
Two species highly expressed at 3H by the microarray were
selected for western blot analysis. RND3 was significantly higher at
both 3H (1.34-fold, P=0.02) and 48H (1.39-fold, P,0.01)
(Fig. 4A). FOS was significantly higher at 48 hours following
exercise (1.16-fold, P,0.05) (Fig. 4B).
Discussion
The sex hormone E2 displays anti-oxidant and membrane
stabilizing properties that could protect skeletal muscle from the
effects of exercise induced muscle damage and influence genetic
expression patterns [50,51]. Using microarray, real time RT-PCR
and protein analyses, we have identified that 8 days of E2
supplementation did not affect the myofibre transcriptome in men.
However, a single bout of eccentric exercise did induce differential
mRNA transcription in the hypertrophic signaling pathways
RhoA and nuclear factor of activated T-cells (NFAT) (Fig. 5),
changes in the phosphorylation status of related signaling proteins
and the protein quantities of two of the upregulated genes.
Of the genes affected early after exercise, one of the greatest
inductions was observed in the novel actin binding protein striated
muscle activator of Rho signaling (STARS). This protein is a muscle-
specific transducer of cytoskeletal signaling in cardiac and skeletal
Figure 1. Expression fold changes in mRNA expression of genes in muscle from baseline after exercise protocol. Graph A – RCAN1
(N=18). Graph B – HMOX1 (N=18). 3H=3 hours post exercise, 48H=48 hours post exercise. Values are mean 6 SEM. **Significant difference vs.
baseline when collapsed across supplementation (P,0.01). ***Significant difference vs. baseline when collapsed across supplementation (P,0.001).
doi:10.1371/journal.pone.0010695.g001
Figure 2. Expression fold changes in mRNA expression of
CAPZA1 in muscle from baseline after exercise protocol.
3H=3 hours post exercise, 48H=48 hours post exercise. N=18. Values
are mean 6 SEM. *Significant difference vs. baseline when collapsed
across supplementation (P,0.05).
doi:10.1371/journal.pone.0010695.g002
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stress [52,53,54,55]. STARS stimulates growth through a mechanism
requiring actin polymerization and Rho GTPase activation,
increasing serum response factor (SRF)-mediated gene transcription
(Fig. 6) [54,55,56,57]. Originallyidentified in cardiac muscle, STARS
mRNA content increases more than 3-fold following the hypertro-
phic signaling of pressure overload [52,53]. More recently, Lamon
et al. identified a 3.4-fold increase in STARS mRNA in human
skeletal muscle following 8 weeks of resistance training [58]. Our
measurementofmorethana 10-foldincrease suggests thatthisgene is
very important for the early signaling for growth and remodeling
following eccentric exercise.
A downstream target of STARS associated with skeletal
muscle hypertrophy and adaptation is the Rho GTPase, RhoA
[58,59]. Rho GTPases are a family of small signaling G proteins
that interact with effector proteins to regulate actin cytoskeleton,
cell cycle progression and gene transcription [3,60,61,62].
These molecular signals switch to an active GTP bound state
under the control of Rho GEFs (guanidine exchange factors),
and return to their inactive GDP bound state by Rho GAPs
(GTPase-activating proteins) [60,63,64]. For the first time, our
array analysis has identified increased expression of two GEFs
(ARHGEF7 and ARHGEF12) and reduced expression of a
GAP (ARHGAP24) that specifically regulate RhoA [60,65].
These gene expression modifications, if translated into altered
protein quantities, could increase the potential for RhoA
activation.
Although increased activity of RhoA protein is necessary for
myogenesis induction, it must be downregulated before myotube
formation can proceed [66,67]. This is achieved by RND3,
Figure 3. Fold change of phosphorylated/total ratio of signaling pathways from baseline after eccentric exercise. BL = baseline, 3H =
3 hours post exercise, 48H=48 hours post exercise. Graph A – p38MAPK (Thr
180/Tyr
182) (N=18). Graph B – GSK-3b (Ser
9) (N=18). Values are mean 6
SEM. **Significant difference vs. baseline when collapsed across supplementation (P,0.01).
doi:10.1371/journal.pone.0010695.g003
Figure 4. Western blot analysis of RND3 and FOS in skeletal muscle after eccentric exercise. BL = baseline, 3H=3 hours post exercise,
48H=48 hours post exercise. Graph A – RND3 (N=18). Graph B – FOS (N=14). Values are mean 6 SEM. *Significant difference vs. baseline when
collapsed across supplementation (P,0.05).
doi:10.1371/journal.pone.0010695.g004
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an essential step of myoblast fusion [62,68,69]. Our damaging
exercise protocol resulted in an early induction of this gene at 3H
and elevated protein content by 48H. Cell culture experiments
have identified that in the presence of growth factors, RND3
mRNA increases of ,1.7-fold result in greater protein content
within 30 h [62]. This in turn inhibits RhoA activity and promotes
myotube formation and elongation [62].
Once activated, RhoA signaling is associated with myogenesis
and actin remodeling in various cell types through regulation of
genes that include DIAPH1 [70,71], CORO1C [72], FLNB [73]
and CAPZA1 [74]. Through SRF activation, RhoA and STARS
also mediate the induction of actin proteins ACTA2 [75],
ACTN1 [76] and members of the AP1 transcription factor
complex: FOS [76,77], FOSB [77] and JUND [78]. Each of
these genes was induced by eccentric exercise at 3H, as identified
by our gene array and targeted real time RT-PCR analysis and
our data indicate that the increased transcription of FOS was
effectively translated into protein, increasing levels significantly by
48H. Although the number of studies investigating these genes
after exercise is few, some support can be found for the
upregulation of select downstream targets. Following eccentric
exercise, the largest induction occurs with the transcription factor
FOS 2–8 hours post exercise (23 to 38-fold increases) [10,79].
Resistance training results in a 2.7-fold increase in ACTN1 after
8 weeks [58]. Thirty minutes of high intensity running increased
the expression of FOS (7.0-fold) FOSB (17.8-fold) and JUND
(7.6-fold) [80]. Given that the mRNA levels for STARS,
associated regulatory and transcription factors and downstream
targeted genes were all significantly elevated 3 h after exercise, it
appears that STARS signaling through a RhoA/SRF pathway is
important for early skeletal muscle remodeling following
damaging exercise.
A second calcineurin influenced signaling pathway identified in
our microarray analysis to be transcriptionally active was nuclear
factor of activated T-cells (NFAT). NFAT proteins exist in the
cytoplasm of cells in a phosphorylated and inactive state [81]. The
influx of calcium following sustained contraction or damage
increases the binding of calcineurin to NFAT, dephosphorylating
conserved serine residues and promoting translocation of NFAT
into the nucleus [81,82,83,84]. Once inside the nucleus, NFAT
cooperatively binds to DNA with transcription factors AP1 and
MAF initiating the transcription of prohypertrophic genes (Fig. 7)
[85]. Our microarray analysis also identified a significant
induction of the genes NFATc1 and MAF at 3H. Along with
the greater expression of the AP1 complex components FOS,
FOSB and JUND, an increased abundance of NFATc1 and MAF
could improve signaling by NFAT.
The NFAT pathway interacts with mitogen activated protein
kinases (MAPK) and glycogen synthase kinase-3b (GSK-3b) for
coordination of the hypertrophic response [84,86]. p38MAPK and
Figure 5. Schematic representation of the transcriptionally
active pathways following exercise induced muscle damage.
Eccentric exercise promoted greater expression of targets within the
STARS/RhoA/AP1 and NFAT/AP1 signaling pathways for hypertrophy
and actin biogenesis and organization.
doi:10.1371/journal.pone.0010695.g005
Figure 6. Regulatory and downstream targets of STARS
transcriptionally active following a single bout of eccentric
exercise. RCAN – regulator of calcineurin; HMOX1 – hemeoxygenase 1;
ARHGEF7 and ARHGEF12 – Rho guanine nucleotide exchange factor 7
and 12; ARHGAP24 – Rho GTPase activating protein 24; RND3 – Rho
family GTPase 3; DIAPH1 – diaphanous homologue 1; CORO1C –
Coronin, actin binding protein 1; FLNB – Filamin B, beta; CAPZA1 –
capping protein (actin filament) muscle Z-line alpha 1; ACTA2 – actin,
alpha 2, smooth muscle, aorta; ACTN1 – actinin, alpha 1; AP1 – activator
protein 1; FOS – FBJ murine osteosarcoma viral oncogene homologue;
FOSB – FBJ murine osteosarcoma viral oncogene homologue B; JUND –
Jun D proto-oncogene.
doi:10.1371/journal.pone.0010695.g006
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rephosphorylating NFAT and promoting its export from the
nucleus [83,86,87]. Although GSK-3b mRNA content was higher
in the microarray, its activity did not change and would not have
affected NFAT nuclear residence. GoMiner analysis identified
MAPK regulation as a transcriptionally active biological process
through the induction of four related kinases (MAPKAPK2,
MAPK6, MAP3K6 and MAP3K8), three related phosphatases
(PP2CA, DUSP8 and DUSP16) and one surface receptor
(ADRB2). Western blotting confirmed that p38MAPK phosphor-
ylation status was lower after exercise, reaching significance by
48H. Lower activity of p38MAPK would assist in the transcrip-
tional activity of NFAT, and may also occur to inhibit the
induction of apoptosis and necrosis [2].
It should be noted that molecules that function in the recovery
and repair of skeletal muscle through other mechanisms were also
induced by our exercise protocol. Similar to other reports, ATF3
[10], MYC [10,34], XIRP1 [88], HBEGF [10] and DNAJB4
[10,34,35] were highly up-regulated (6.1 to 28.4-fold) early after
exercise. In addition, the altered mRNA content of members of
the signaling pathways ILK, RAN and PI3K/AKT identified
them as being transcriptionally active. Their respective functions
in actin cytoskeleton remodeling [89], transport across the nuclear
envelope for gene expression [90] and protein synthesis [91] relate
to the top biological functions returned by gene ontology analysis.
Interestingly, the biological function that contained the greatest
number of molecules was cancer (233 molecules), likely due to
similar alterations to the regulation of cellular growth experienced
with both exercise and cancer.
Maintained muscle contractions and exercise-induced damage
to the sarcoplasmic reticulum and sarcolemma may result in the
accumulation of excess calcium, known as Ca
2+ overload [5,92].
As a signaling molecule, Ca
2+ binds to calcineurin, activating
both STARS [52] and NFAT [81,82,83,84,93]. Unrestrained
calcineurin activity can be regulated in skeletal and cardiac
muscle by the inhibitors regulator of calcineurin 1 (RCAN1, aka
MCIP1, DSCR1) [81,94,95,96,97] and hemeoxygenase 1
(HMOX1) [98]. Increased mRNA content of RCAN1 was
identified in microarray and targeted real time RT-PCR,
confirming a previous gene expression profile that also identified
an increase following exercise (3.8-fold) [34]. RT-PCR also
identified significant increases in HMOX1 at both time points
after exercise, similar to the 8-11-fold induction following 5 days
of resistance training [99]. Together, the upregulation of these
two calcineurin inhibitors identifies the importance of regulating
the elevated calcineurin activity that occurred following unac-
customed eccentric exercise [97].
The primary mechanism through which estrogens influence the
growth, differentiation and function of tissues occurs via the
estrogen receptors ERa and ERb [31,32,100]. As transcription
factors, active homodimers and heterodimers of ERa and ERb
bind to estrogen response elements (EREs) in nuclear and
mitochondrial DNA, increasing the transcription of target genes
[101]. In a nongenomic manner, E2 also interacts with a number
of proteins that include endothelial nitric oxide synthase (eNOS)
and MAPK, altering the signals that modulate cellular differen-
tiation, migration and survival [102,103,104]. Our observation
that the myofibre transcriptome was unaffected by E2 is surprising.
Although women have higher E2 concentrations than men,
protein quantities of ERa and ERb are similar and our
supplementation protocol successfully increased circulating E2 to
the level seen during the luteal phase of the menstrual cycle in
healthy women [105,106]. This suggests that the differential
expression between men and women of genes involved in
metabolism and growth regulation [36,37,38] may result from
factors beyond E2 alone; factors that may include variations in
body composition, X-chromosome genes, and/or other sex
hormones (i.e., progesterone).
These results indicate that E2 supplementation does not affect
the transcriptional pattern in skeletal muscle following eccentric
exercise in men. However, the stress of a single bout of exercise
induced a transcriptional response in two signaling pathways,
STARS/RhoA/AP1 and NFAT/AP1, providing important in-
sights for future research into the early hypertrophic response.
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